Viewing nowSiglib 100 mg (Sitagliptin Hydrochloride Hydrate)
Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Eden Pharma Co., Ltd.

MFDS item code 202005196 · Approved 2020.07.20 · Insurance code 628901870
Improvement of blood glucose control in type 2 diabetes mellitus
This medication is used in conjunction with dietary and exercise therapy to improve blood sugar control in patients with type 2 diabetes. It can be administered alone to patients starting treatment for the first time, and if sufficient blood sugar control is not achievable with monotherapy, it is used in combination with metformin. Additionally, it can enhance blood sugar control when used along with other diabetes medications, including sulfonylureas, metformin, thiazolidinediones, and insulin. If blood sugar control is inadequate despite the use of multiple medications, this drug can be added to improve effectiveness. This variety of treatment methods can effectively enhance blood sugar control in patients.
This medication is administered at 100 mg once daily as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This medication may be taken with or without food. When administered in combination with a sulfonylurea or insulin, reduction of the sulfonylurea or insulin dose may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Patients with renal impairment As dose adjustment according to renal function is required, assessment of renal function is recommended before and periodically after starting this medication. 1. No dose adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is required in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily to patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily to patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medication may be administered regardless of the timing of dialysis.
This medication may cause severe allergic reactions after administration, so if symptoms such as skin rash, difficulty breathing, or swelling of the face or neck occur, use should be discontinued immediately and consult a physician. Moreover, this drug may cause serious inflammation of the pancreas called pancreatitis, so if symptoms such as abdominal pain, vomiting, or loss of appetite occur, notify medical personnel immediately. This drug should not be used in patients with type 1 diabetes or diabetic ketoacidosis, and should not be administered to patients who have an allergy to this drug or its components. Patients with impaired kidney function may have the drug stay in their body for a prolonged period, so dosage adjustments are required, and it is important to undergo regular kidney function testing. When taking this drug, caution should be exercised regarding symptoms of hypoglycemia, and particularly when taken with insulin or sulfonylureas, the risk of hypoglycemia may increase, thus frequent blood sugar checks are necessary. If severe joint pain or skin blistering symptoms appear, consult a physician immediately, and the use of this medication can be discontinued if necessary. Women who are pregnant or nursing are advised not to take this medication, and safety for children or adolescents under 18 has not been established. This medication does not show significant interactions when taken together with other diabetes treatments or certain medications; however, caution may be required when combined with specific drugs, so consult medical personnel. In cases of overdose, measures should be taken to remove the drug from the gastrointestinal tract and monitor the condition using an electrocardiogram, and blood dialysis may be considered if necessary. Lastly, in elderly patients, dosage should be determined carefully considering the possibility of reduced kidney function, and it is recommended to regularly evaluate kidney function.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air or moisture infiltration, maintaining the storage temperature between 1 and 30 degrees Celsius. By storing it this way, the efficacy of the medication can be preserved for a long time.
Light orange, round, biconvex film-coated tablet
30 tablets/box [(10 tablets/PTP x 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Eden Pharma Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Korea United Pharm., Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 28.35mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.